Portfolio Lab

CVS HEALTH Corp

  • Stock
  • Ticker CVS
  • ISIN US1266501006
  • NYSE

Consumer, non-cyclical · Food and discount retail · USA

$80.84 +1.00%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of CVS HEALTH Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

CVSGlobal equities (VT)

$10,000 grew to $14,857. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −56.8% in 12/2024, measured from the peak in 02/2022. It took 51 months to get back to the old peak.

1-year return
+9.5%
5-year return p.a.
+0.5%
10-year return p.a.
+4.0%
Volatility p.a.
29.8%
Largest decline
−56.8%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue97,71094,58898,915102,871105,693100,426106,096108,399
Gross profit42,44243,53144,91045,82646,63344,98247,23447,214
Operating income2,3683,3742,381-3,2072,1124,6804,7033,566
EBITDA3,5154,5283,552-2,0733,2595,7955,8294,698
Net income1,6441,7791,021-3,9752,9432,9432,9792,172
Earnings per share1.311.410.80-3.132.322.302.311.68
Balance sheet
Total assets253,215255,585258,343255,327253,538252,974253,768258,075
Liabilities177,485178,475180,792182,217178,156175,337173,869177,386
Equity75,56076,92977,37972,92875,21477,45679,70280,497
Cash8,58610,07611,7879,0988,4539,54211,32911,738
Cash flow
Operating cash flow1,8604,5561,8977963,3904,2496,3454,724
Capital expenditure-768-743-607-698-784-849-691-817
Free cash flow1,0923,8131,290982,6063,4005,6543,907

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +84.3%, weakest 2024 at −40.8%. 3 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
4 Nov 2026$1.68
5 Aug 2026$2.31
6 May 2026$2.30
10 Feb 2026$2.32
29 Oct 2025−$3.13
31 Jul 2025$0.80
1 May 2025$1.41
12 Feb 2025$1.31
6 Nov 2024$0.07
7 Aug 2024$1.41
1 May 2024$0.88
7 Feb 2024$1.59

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€94bn
Market cap in trading currency
$103bn
Enterprise value
$88.5bn
P/E
9.4
P/S
0.25
P/B
1.28
EV/Sales
0.21
EV/EBITDA
4.5
Earnings yield
10.7%
FCF yield
15.1%

Results (last four quarters)

Revenue
$421bn
Gross profit
$186bn
EBITDA
$19.6bn
Net income
$11.0bn
Earnings per share
$8.61
Revenue per share
$328.74
Revenue growth
+5.4%
Earnings growth
–

Profitability

Gross margin
44.2%
Operating margin
3.6%
Net margin
2.6%
Return on equity
14.4%
Return on assets
4.3%

Balance sheet and cash flow

Cash
$14.9bn
Cash per share
$11.64
Financial debt
–
Debt/equity %
–
Current ratio
0.85
Book value per share
$62.91
Operating cash flow
$18.7bn
Free cash flow
$15.6bn

Dividend

Dividend yield
3.29%
Dividend (12 months)
$2.66
Yield (12 months)
3.29%
Payout ratio
31%
Ex-dividend date
22 Oct 2026

Shares and trading

Shares outstanding
1.28bn
Volume
10.4m
Avg. volume 3 months
8.98m
Relative volume
1.1

Price and technicals

Price
$80.84
1 day
+1.0%
52-week high
$110.60
52-week low
$70.08
Distance to 52-week high
−26.9%
Distance to 52-week low
+15.4%
Distance to 50-day line
−8.6%
Distance to 200-day line
−9.5%
RSI (14)
37
Volatility 1M
57.8%

Performance

1 week
−9.5%
1 month
−14.4%
3 months
−14.1%
6 months
−13.3%
YTD
+1.9%
1 year
+5.6%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has CVS performed since 11/2016?

$10,000 grew to $14,857 by 20 Nov 2026, which is +4.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is CVS?

Volatility was 29.8% per year, measured on monthly returns. The largest decline from a peak was −56.8%, with the low in 12/2024.

How does CVS compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CVS returned +4.0% at 29.8%. The correlation of monthly returns was 0.40; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

CVS HEALTH Corp (CVS): Return and risk | Portfolio Lab